by Elisa Cascade; Amir H. Kalali, MD; Sagar Mehra; and Jonathan M. Meyer, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global
by Jeffrey Ventimiglia and Amir H. Kalali, MD Mr. Ventimiglia is Analyst, Strategy and Solutions, Global Customer Management, Quintiles, Inc., Durham, North Carolina; Dr. Kalali is Vice President, Global Therapeutic
by Chris B. Aiken, MD, and Carolyn Orr, PMH-NP Dr. Aiken is Director, Mood Treatment Center, and Instructor in Clinical Psychiatry, Wake Forest University School of Medicine Winston-Salem, North Carolina.
by Elisa Cascade; Amir H. Kalali, MD; and Sharon B. Wigal, PhD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group
by Susan Lenderts, BA; Amir H. Kalali, MD; and Peter Buckley, MD Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
by Susan Lenderts, BA; Amir H. Kalali, MD; and Richard Weisler, MD Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
Parikshit Deshmukh, MD; Guarav Kulkarni, MD; and Drew Barzman, MD Dr. Deshmukh is a resident with the Division of Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio; Dr. Kulkarni is
by James J. McGough, MD, and Stephen V. Faraone, PhD Dr. McGough is Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School
by Tanvir Singh, MD; Ashwin Prakash, MD; Theodore Rais, MD; and Neeta Kumari, MD, MPH Dr. Singh is Assistant Professor, Department of Child and Adolescent Psychiatry, University of Toledo Medical
by Susan Lenderts and Amir Kalali, MD Ms. Lenderts is Manager, Strategic Analytics, Quintiles, Inc.,/Innovex, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc.,
by Kevin M. Nasky, DO; George L. Cowan, MD, MS; and Douglas R. Knittel, MD Dr. Nasky is Staff Psychiatrist, Department of Psychiatry, Naval Medical Center, Portsmouth; Dr. Cowan is
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by David Feifel, MD, PhD Dr. Feifel is Professor, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center,
by David R. Spiegel, MD, and Lindsey Finklea, MD From Eastern Virginia Medical School, Department of Psychiatry and Behavioral Science, Norfolk, Virginia
by Elisa Cascade; Amir H. Kalali, MD; and Sidney H. Kennedy, MD, FRCPC Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by
by Elisa Cascade; Amir H. Kalali, MD; Joseph A. Kwentus, MD; and Murtuza Bharmal, PhD, BPharm Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice
Should Psychiatrists Use Atypical Antipsychotics to Treat Nonpsychotic Anxiety?
by Ronald Pies, MD Professor of Psychiatry, SUNY Upstate Medical University, Syracuse, New York; and Clinical Professor of Psychiatry, Tufts University School of Medicine, Boston, Massachussetts
Read More